A blood NfL cut-off of 16.6 pg/ml allowed to discriminate 20 PD patients from 58 CBS/PSP patients with a sensitivity of 88.7% and a specificity of 87.8% (AUC 0.936) [20]. This evidence concerns the gene NEFL and Parkinson disease.